A carregar...
Hormone receptor–positive, HER2-negative metastatic breast cancer: redrawing the lines
Estrogen receptor modulators and estrogen deprivation have become standards of care for hormone receptor–positive metastatic breast cancer. However, after traditional first-line endocrine monotherapy treatment, the disease typically progresses despite the initial high rate of clinical benefit. Multi...
Na minha lista:
| Publicado no: | Curr Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Multimed Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6001771/ https://ncbi.nlm.nih.gov/pubmed/29910656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.25.4000 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|